Related Experiment Videos
[Imiquimod creme 5 per cent--a new agent for topical treatment of external condylomata]
1H:S Bispebjerg Hospital, dermato-venerologisk afdeling.
Ugeskrift for Laeger
|December 28, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Clinical severity and prognosis of hand eczema.
The British journal of dermatology·2009
Severity of hand eczema assessed by patients and dermatologist using a photographic guide.
The British journal of dermatology·2007
Treatment of hand eczema.
Skin therapy letter·2003
Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts--results of an open-label, multicentre Phase IIIB trial.
International journal of STD & AIDS·2001
Reduced nickel sensitivity in young Danish women following regulation of nickel exposure.
Contact dermatitis·2001
[Myelin oligodendrocyte glycoprotein antibody-associated disease].
Ugeskrift for laeger·2026
[Clinical pharmacogenetics and the use of biobanks].
Ugeskrift for laeger·2026
[Cutaneous myiasis].
Ugeskrift for laeger·2026
[When radiology does not rule out intracranial hypertension].
Ugeskrift for laeger·2026
[Intracranial hypotension].
Ugeskrift for laeger·2026
[Large macrocystic lymphatic malformation in a newborn].
Ugeskrift for laeger·2026
Low-dose colchicine: a potential augmenting agent in the treatment of refractory mood disorders.
Acta neuropsychiatrica·2026
[Mechanism of modified Shaofu Zhuyu Decoction in antagonizing endometriosis angiogenesis based on mitophagy mediated by CaMKKβ/AMPK/HIF-1α signaling pathway].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2026
[Ginsenoside Rg_1 attenuates OGD/R induced HT22 cell damage by inhibiting oxidative stress via ROS-ATM-CHK2 pathway].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2026
Ginsenoside Ra1 alleviates endothelial barrier dysfunction and multi-organ injury in experimental sepsis via NMMHC IIA inhibition.
British journal of pharmacology·2026